Litcius/Paper detail

Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2

Julia Velez, Brandon Dale, Kwang‐Su Park, H. Ümit Kanıskan, Xufen Yu, Jian Jin

2024European Journal of Medicinal Chemistry37 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryEZH2Non canonicalComputational biologyStereochemistryBiochemistryCell biologyMethylationGeneBiologyProtein Degradation and InhibitorsHistone Deacetylase Inhibitors ResearchCancer-related gene regulation
Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2 | Litcius